The Italian neuromodulation startup Newronika has secured a European approval for its closed-loop, adaptive implant for ...
Newronika announced today that it received CE mark approval for its AlphaDBS device for treating Parkinson's disease.
Newronika, a leader in neuromodulation and adaptive deep brain stimulation (DBS) technology, announced today that it has ...
GlobalData on MSN3d
Newronika’s DBS device gains CE Mark approval for Parkinson’s treatmentNewronika has secured CE Mark approval for its AlphaDBS device aimed at the treatment of Parkinson's disease (PD), in Europe.
Hosted on MSN1mon
Newronika secures FDA’s IDE to begin adaptive deep brain stimulation system trialNewronika has received an investigational device exemption (IDE) for its adaptive deep brain stimulation (DBS) system from the US Food and Drug Administration (FDA), allowing it to begin a pivotal ...
MILAN, Feb. 13, 2025 /PRNewswire/ -- Newronika, a global leader in advanced deep brain stimulation, is pleased to announce the successful closing of its €13.6 million Series B funding round.
MILAN, Feb. 5, 2025 /PRNewswire/ -- Newronika, the developer of groundbreaking adaptive deep brain stimulation technology, is proud to announce the receipt of an Investigational Device Exemption ...
MILAN, March 24, 2025 /PRNewswire/ -- Newronika, a leader in neuromodulation and adaptive deep brain stimulation (DBS) technology, announced today that it has received CE Mark approval for its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback